Inaugural Center for Cardiovascular Disease Prevention Symposium: Innovating Prevention- From Precision Science to Real World Impact

September 26, 2026

This inaugural symposium highlights a comprehensive and multidisciplinary approach to cardiovascular disease (CVD) prevention across the lifespan. The program integrates precision science, clinical implementation, community engagement, and innovation to address major drivers of cardiovascular morbidity and mortality. Through keynote lectures, pathway-focused scientific sessions, case-based learning, panel discussions, and innovation showcases, attendees will explore prevention strategies in atherosclerosis, arrhythmias and sudden cardiac death, heart failure and cardiomyopathy, social determinants of health, women’s cardiovascular health, and cardio-oncology. The symposium also highlights emerging technologies including artificial intelligence, advanced imaging, wearable devices, omics-based risk prediction, and novel therapeutics.

Target Audience

Nurse
Nurse Practitioner
Pharmacist
Physician
Physician Assistant

Learning Objectives

1. Apply contemporary evidence-based prevention strategies across the spectrum of cardiovascular disease, including atherosclerosis, arrhythmias, sudden cardiac death, heart failure, and cardiomyopathy.
2. Integrate precision medicine approaches - including advanced cardiovascular imaging, genomics, proteomics, metabolomics, and biomarker-based assessment - to enhance cardiovascular risk stratification and early disease detection.
3. Evaluate and incorporate emerging prevention technologies, including artificial intelligence, wearable monitoring devices, digital health platforms, and electronic health record–based tools, into cardiovascular prevention strategies.
4. Implement multidisciplinary and lifespan-based prevention strategies to reduce the risk of first cardiovascular events and prevent disease progression or recurrence in diverse patient populations.
5. Incorporate social determinants of health, community partnerships, and population health strategies into cardiovascular prevention programs to improve health equity, access to care, and long-term outcomes.
6. Recognize and address sex-specific, pregnancy-related, genetic, and treatment-associated cardiovascular risks, including prevention strategies in women’s cardiovascular health, inherited cardiac conditions, and cardio-oncology populations.
7. Translate scientific discovery and innovation into clinical and community practice by identifying barriers, facilitators, and implementation strategies that enable sustainable and scalable cardiovascular prevention programs.

Course summary
Course opens: 
04/07/2026
Course expires: 
10/10/2026
Event starts: 
09/26/2026 - 8:30am EDT
Event ends: 
09/26/2026 - 2:30pm EDT
UPMC Herberman Conference Center
Pittsburgh, PA
United States


In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

This activity is approved for the following credit:  AMA PRA Category 1 Credit™, ANCC, ACPE, and AAPA Category 1 CME. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
 

Please login or register to take this course.

** Credit(s) must be claimed within 10 days after activity start date. Credit(s) will not be awarded after this date. **